Follow-The-Filings

Security · featured owners

STRO Sutro Biopharma Inc.

Health Care COM SHS Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management exited 2026 Q2 last 2026 Q1 0.63% Exit −0.63% 190,671 $5M history

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,7.01,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
10-Q
DEFA14A
424B3
8-K 1.02,2.02,9.01
10-K
424B5
8-K 1.01,7.01,9.01
8-K 8.01
8-K 3.03,5.03,8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 7 rows shown

Filed Form Detail Links
4 Period Jun 5, 2026 · 8 forms
4 Period Jun 2, 2026
4 Period Mar 4, 2026 · 2 forms
4 Period Mar 1, 2026
4 Period Mar 2, 2026
4 Period Mar 1, 2026 · 2 forms
4 Period Dec 23, 2025 · 10 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $153.73M $62.04M $102.48M
Net income -$106.79M -$227.46M -$191.09M
Net margin * -69.5% -366.6% -186.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $421.54M $343.31M $150.93M
Total non-current assets * $49.19M $43.9M $22.9M
Total assets $470.74M $387.21M $173.83M
Total current liabilities $93.75M $131.89M $75.13M
Total non-current liabilities * $227.34M $210.71M $231.15M
Total equity $149.65M $44.6M -$132.45M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$111.62M -$191.54M -$177.23M
Cash from investing -$3.92M $218.51M $45.01M
Cash from financing $137.55M $94.05M $0.044M
Net change in cash $22.01M $121.02M -$132.17M

ownership over time

filing count by report period · click a bar for that quarter’s holders